{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:12:10Z","timestamp":1760141530648,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejso.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T17:31:16Z","timestamp":1504200676000},"page":"2143-2149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic value of local relapse for patients with endometrial cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Y.","family":"Dabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Uzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bendifallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ouldamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lavou\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Canlorbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Raimond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Graesslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Collinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bricou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9149-1663","authenticated-orcid":false,"given":"C.","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2017.08.004_bib1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"Suppl. 1","key":"10.1016\/j.ejso.2017.08.004_bib2","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ejso.2017.08.004_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crad.2006.06.015","article-title":"Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis","volume":"62","author":"Sohaib","year":"2007","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1016\/j.ejso.2017.08.004_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.08.004_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0090-8258(84)90063-5","article-title":"Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients","volume":"17","author":"Aalders","year":"1984","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2017.08.004_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0090-8258(92)90134-5","article-title":"Detection and patterns of treatment failure in 300 consecutive cases of \u201cearly\u201d endometrial cancer after primary surgery","volume":"47","author":"Podczaski","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.08.004_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ygyno.2006.03.011","article-title":"Salvage cytoreductive surgery for recurrent endometrial cancer","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.08.004_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ygyno.2007.06.002","article-title":"Efficacy of routine follow-up in patients with recurrent uterine cancer","volume":"107","author":"Smith","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.08.004_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2017.08.004_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2010.08.013","article-title":"Predictive factors for prolonged survival in recurrent endometrial carcinoma: implications for follow-up protocol","volume":"119","author":"Otsuka","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.08.004_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2017.08.004_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1470-2045(11)70070-5","article-title":"Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)","volume":"12","author":"Ballester","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2017.08.004_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet"},{"key":"10.1016\/j.ejso.2017.08.004_bib14","unstructured":"Cancer de L'endom\u00e8tre: synth\u00e8se des recommandations \u2013 Ref: RECOENDOSYN10 | Institut National Du Cancer [Internet]. [Cited 2017 Jan 6]. Available from: http:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Cancer-de-l-endometre-synthese-des-recommandations."},{"issue":"Suppl. 6","key":"10.1016\/j.ejso.2017.08.004_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2017.08.004_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/ijgc-00009577-200307000-00009","article-title":"Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study","volume":"13","author":"Sartori","year":"2003","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"issue":"2","key":"10.1016\/j.ejso.2017.08.004_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"9717","key":"10.1016\/j.ejso.2017.08.004_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet Lond Engl"},{"issue":"13","key":"10.1016\/j.ejso.2017.08.004_bib19","first-page":"1742","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2013A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"4","key":"10.1016\/j.ejso.2017.08.004_bib20","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3892\/ol.2014.2362","article-title":"Natural history of recurrences in endometrial carcinoma","volume":"8","author":"Sorbe","year":"2014","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.ejso.2017.08.004_bib21","first-page":"403","article-title":"Vaginal and pelvic recurrences in stage I and II endometrial carcinoma\u2013survival and prognostic factors","volume":"32","author":"Blecharz","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.08.004_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/gyno.2000.5727","article-title":"Results of radical radiotherapy for recurrent endometrial cancer","volume":"77","author":"Wylie","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2017.08.004_bib23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/1097-0142(19940815)74:4<1303::AID-CNCR2820740420>3.0.CO;2-G","article-title":"Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer","volume":"74","author":"Sears","year":"1994","journal-title":"Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317306388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317306388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:24:20Z","timestamp":1760059460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798317306388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0748798317306388"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2017.08.004","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of local relapse for patients with endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}